| W |
|
Walking and Modulation of Cardiovascular Risk Factors in Three European Populations: Results from the IMMIDIET Project
|
| Zito F, Di Castelnuovo A, Dirks C, Cappuccio FP, Siani A, Arnout J, Donati MB, de Gaetano G, Iacoviello L, on behalf of the IMMIDIET Study Group |
| |
|
Warfarin and Plasma Concentrations of Some Metalloproteinases in Patients with Popliteal Arterial Aneurysm
|
| Kozak M, [Scaron]talc J, Tominec U |
| |
|
Warfarin Therapy in AF Patients: Females Are Still at Risk
|
| Poli D, Cecchi E, Antonucci E, Mannini L, D'Agnano G, Sabatini F, Martini A, Gensini GF, Abbate R, Prisco D |
| |
|
Warm-Up Activity Attenuates Platelet-Neutrophil Interaction Induced by Vigorous Exercise in Men
|
| Wang JS |
| |
|
WAY-197697, a P-selectin Antagonist, Reduces Atherosclerosis in Apolipoprotein E Deficient Mice
|
| Clerin V, Resmini C, Wong T, Bedard P, Shaw G, Kaila N, DeBernardo S, Janz K, Schaub RG, Keith Jr. JC |
| |
|
We Still Need to Organize French Anticoagulation Clinics
|
| Cambus JP, Mahé I, Siguret V, Gouin I, Drouet L, Bal dit Sollier C |
| |
|
What All That Thrombin Is for
|
| Orfeo T, Butenas S, Brummel-Ziedens KE, Mann KG |
| |
|
What Causes Patients with Acquired Thrombotic Thrombocytopenic Purpura to Relapse?
|
| Wilken A, Böhm M, Scharrer I |
| |
|
What Is the Real Contribution of Standardized Pre-test Clinical Probability Scores and D-dimer Assays to the Diagnostic Management of Deep Vein Thrombosis? Systematic Review of Clinical Outcome Studies
|
| El Kheir D, Söhne M, Gerdes V, Büller H |
| |
|
Which Haemostatic Variables Add to the Prediction of Cardiovascular Events by Conventional Risk Factors? The Caerphilly Study
|
| Rumley A, Lowe G, Smith A, Patterson C, Ben-Shlomo Y, Yarnell J |
| |
|
Which Patients Require Extended Secondary Prophylaxis?
|
| Prandoni P |
| |
|
Whole Blood and Plasma ‘Thrombus Generation’ Derived from Thromboelastography as an Alternative to Endogenous Thrombin Potential
|
| Tappenden KA, Gallimore MJ, Winter M, Evans G, Jones DW |
| |
|
Whole Blood Clotting Time in the Presence of the Platelet PAR-1 Activating Peptide TRAP-6 Predicts Post-operative Bleeding in Open-heart Surgery – A Pilot Study Utilizing Free Oscillation Rheometry
|
| Lindahl TL, Cederholm I |
| |
|
Whole Blood Tissue Factor Triggered Thromboelastography. A Sensitive Assay for the Monitoring of Anticoagulant Effect of LMWH after Stenting in Patients with Carotid Artery Disease
|
| Kostantinidis K, Gerasimidis T |
| |
|
WILFACTIN: Efficacy and Safety Evaluation of WILFACTIN (a Triple Secured Von Willebrand Factor Product with a Low Factor VIII Content) in Women with Severe Von Willebrand Disease during Gynaecological/Obstetrical Events
|
| Borel-Derlon A, Fressinaud E, Bertrand MA, Volot F, Stieltjes N, Rothschild C, Torchet MF, Henriet C, Bridey F, Tellier Z |
| |
|
Withdrawn
|
|
| |
